A Phase III, Multicenter, Randomized, Open-Label Study Comparing Atezolizumab (Anti-PD-L1 Antibody) in combination with adjuvant Anthracycline/Taxane-based Chemotherapy versus Chemotherapy Alone in patients with operable Triple-Negative Breast Cancer

  • Sabanathan, Dhanusha (Primary Chief Investigator)
  • Kefford, Richard (Chief Investigator)
  • Chapman, Nicola (Research Coordinator)
  • Butala, Radhika (Research Coordinator)

Project: Other

Project Details

StatusActive
Effective start/end date5/08/1924/10/23